1 Unstoppable Pharmaceutical Stock Investors Shouldn't Sleep On

Eli Lilly may be on the verge of another breakthrough, thanks to its hit GLP-1 medications.One of the hottest areas in the pharmaceutical space right now is weight loss. Glucagon-like peptide-1 (GLP-1) medications such as Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound have become staples for treating diabetes and obesity.Eli Lilly (LLY 1.19%) is the developer of Mounjaro and Zepbound, two popular medications used to treat those conditions. The main compound in each drug is called tirzepatide, and Lilly h ...